📰 Mads Daugaard News
Mads Daugaard News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Mads Daugaard. Real-time updates on events, politics, business and more.
April 24, 2024
Rakovina Therapeutics Inc (TSX-V:RKV), a Canadian biotechnology company focused on developing innovative therapies for the treatment of cancer, experienced...
April 9, 2024
VANCOUVER, British Columbia, April 09, 2024 -- Rakovina Therapeutics Inc. , , a biopharmaceutical company dedicated to improving the lives of cancer patients through the development of novel...
March 27, 2024
Rakovina Therapeutics Inc. , ("Rakovina" or the "Company"), a biopharmaceutical company dedicated to improving the lives of cancer patients through the development of novel DNA-damage response inhibitor therapeutics, is pleased to announce a...
March 27, 2024
Company Leveraging Deep Docking AI Drug Discovery PlatformVANCOUVER, British Columbia, March 27, 2024 -- Rakovina Therapeutics Inc. , , a biopharmaceutical company dedicated to improving the lives...
November 28, 2023
Rakovina Therapeutics Inc (TSX-V:RKV) on Monday announced the appointment of Professor Artem Cherkasov to its Scientific Advisory Board (SAB). Cherkasov is...
June 9, 2023
Rakovina Therapeutics Inc (TSX-V:RKV), which is developing new cancer treatments based on novel DNA-damage response (DDR) technologies, presented promising...
April 20, 2023
Rakovina Therapeutics Inc (TSX-V:RKV) revealed new data indicating that its kt-3000 lead candidate could be effective in treating certain tumors resistant...
April 20, 2023
VANCOUVER, British Columbia, April 20, 2023 -- Rakovina Therapeutics Inc. today announced the presentation of new data describing the progress of the Company’s kt-3000 drug development... | April 20, 2023